Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
Clinical trial NCT01430429 · TERMINATED
Trial details
- NCT number
- NCT01430429
- Sponsor
- Light Chain Bioscience - Novimmune SA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.